IDT Australia Sees Revenue Surge Despite Ongoing Losses

The latest announcement is out from IDT Australia Limited ( (AU:IDT) ).

IDT Australia Limited reported an 83% increase in revenues to $10.5 million for the half-year ended December 31, 2024, but the company saw a reduced loss after tax of $3.3 million, down 15.8% from the previous year. This improvement in financial performance indicates a positive trajectory for IDT Australia, although the company did not declare any dividends for the period, reflecting ongoing financial prudence amidst recovery efforts.

More about IDT Australia Limited

IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacture of pharmaceutical products and services.

YTD Price Performance: 4.55%

Average Trading Volume: 146,501

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$47.55M

For detailed information about IDT stock, go to TipRanks’ Stock Analysis page.